| __timestamp | Bristol-Myers Squibb Company | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 382096000000 |
| Thursday, January 1, 2015 | 5920000000 | 345927000000 |
| Friday, January 1, 2016 | 4940000000 | 312303000000 |
| Sunday, January 1, 2017 | 6411000000 | 325441000000 |
| Monday, January 1, 2018 | 6345000000 | 368298000000 |
| Tuesday, January 1, 2019 | 6148000000 | 492381000000 |
| Wednesday, January 1, 2020 | 11143000000 | 455833000000 |
| Friday, January 1, 2021 | 10195000000 | 526087000000 |
| Saturday, January 1, 2022 | 9509000000 | 633325000000 |
| Sunday, January 1, 2023 | 9299000000 | 729924000000 |
| Monday, January 1, 2024 | 11159000000 | 729924000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Bristol-Myers Squibb's R&D expenses grew by approximately 105%, peaking in 2020 with a 150% increase compared to 2014. Meanwhile, Takeda's R&D spending surged by nearly 91% over the same period, with a notable 91% increase from 2014 to 2023. This strategic focus underscores the companies' dedication to advancing medical breakthroughs. However, the data for 2024 is incomplete, highlighting the dynamic nature of financial forecasting in the pharmaceutical industry. As these giants continue to invest heavily in R&D, the future of healthcare innovation looks promising.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
R&D Insights: How Takeda Pharmaceutical Company Limited and Madrigal Pharmaceuticals, Inc. Allocate Funds
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated